KKI-04

N/A

Report date: 2025/06/11 10:22:35
NME

Base Information

Drug NameKKI-04
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonistsAnticancer protein kinase inhibitors
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAll India Institute Of Medical Sciences, New Delhi
China Registration ClassN/A

Develop Information

Active CompaniesAll India Institute Of Medical Sciences, New Delhi
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A